Healthcare provider profile · identity verified

Perry G Farb, DO

Family Practice · SPRINGFIELD, MA · NPI 1114902848

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	340	41
Trazodone Hcl	Trazodone Hcl	250	26
Mirtazapine	Mirtazapine	186	12
Omeprazole	Omeprazole	186	22
Furosemide	Furosemide	169	20
Lisinopril	Lisinopril	156	15
Duloxetine Hcl	Duloxetine Hcl	150	13
Amlodipine Besylate	Amlodipine Besylate	147	19
Metoprolol Succinate	Metoprolol Succinate	146	19
Sertraline Hcl	Sertraline Hcl	143	17
Levothyroxine Sodium	Levothyroxine Sodium	131	17
Gabapentin	Gabapentin	125	15
Metoprolol Tartrate	Metoprolol Tartrate	122	11
Eliquis	Apixaban	116	13
Montelukast Sodium	Montelukast Sodium	112	14
Losartan Potassium	Losartan Potassium	102	13
Metformin Hcl	Metformin Hcl	99	13
Aripiprazole	Aripiprazole	98	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	94	11
Tamsulosin Hcl	Tamsulosin Hcl	92	11
Simvastatin	Simvastatin	85	suppressed
Famotidine	Famotidine	81	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	73	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	73	suppressed
Allopurinol	Allopurinol	71	suppressed
Risperidone	Risperidone	61	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	suppressed
Potassium Chloride	Potassium Chloride	58	suppressed
Memantine Hcl	Memantine Hcl	56	suppressed
Galantamine Hbr	Galantamine Hbr	55	suppressed
Midodrine Hcl	Midodrine Hcl	54	suppressed
Meclizine Hcl	Meclizine Hcl	52	suppressed
Bupropion Hcl	Bupropion Hcl	49	suppressed
Constulose	Lactulose	49	suppressed
Finasteride	Finasteride	44	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	suppressed
Topiramate	Topiramate	39	suppressed
Baclofen	Baclofen	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	22
Lamotrigine	Lamotrigine	36	suppressed
Atenolol	Atenolol	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Sucralfate	Sucralfate	35	suppressed
Prednisone	Prednisone	33	13
Buspirone Hcl	Buspirone Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Loperamide	Loperamide Hcl	32	11
Olanzapine	Olanzapine	32	suppressed
Jardiance	Empagliflozin	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Divalproex Sodium Er	Divalproex Sodium	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clonazepam	Clonazepam	26	suppressed
Glipizide	Glipizide	26	suppressed
Calcitriol	Calcitriol	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	23	suppressed
Benztropine Mesylate	Benztropine Mesylate	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Ozempic	Semaglutide	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Valsartan	Valsartan	18	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Chlorthalidone	Chlorthalidone	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error